The questions that matter most don't sort neatly by industry. A dissertation defence, an M&A thesis, a clinical evidence review, a policy cost-benefit analysis — they all share the same structure: contested evidence, high stakes, and a wrong answer that costs more than the right one would have. Augle is built for that structure, regardless of domain.
Research questions don't have clean answers before the committee does. Augle maps what's settled, what's contested, and what's genuinely unknown in your methodology — before the defence, before the submission, before the study section finds it first.
“Does experience sampling via smartphone provide sufficient ecological validity to support attentional state claims in naturalistic environments?”
High-stakes hypothesis decisions require more than a literature review. Augle stress-tests your evidence base against the strongest objections in the field — surfacing validity gaps before they become rejection vectors or, worse, replication failures.
“Is the protein folding hypothesis supported by the current cryo-EM evidence base, or are the resolution limitations material to the claim?”
Policy testimony and impact assessments rest on evidence that gets challenged in real time. Augle produces a structured map of what the evidence actually supports — and what it doesn't — so you're never the one who finds out at the hearing.
“Does the proposed infrastructure bill's cost-benefit methodology adequately account for climate-adjusted risk over a 30-year horizon?”
Case theory, expert evidence, and regulatory applicability all need to survive adversarial challenge. Augle's Contrarian plays opposing counsel before opposing counsel does — surfacing the strongest objections and their resolution conditions while you still have time to respond.
“Does the expert testimony meet the Daubert threshold given the methodological assumptions in the underlying study design?”
TAM assumptions, growth theses, and portfolio pivot decisions all depend on evidence that isn't neutral. Augle stress-tests the claim before the IC does — and when the evidence doesn't support the thesis, it says so, clearly, with the specific construct validity issue identified.
“Does the TAM assumption in this Series A deck reflect the addressable market or the theoretical maximum?”
Policy reports and intervention recommendations carry institutional weight. Augle maps the evidence landscape before publication — distinguishing what the data supports from what you wish it supported, and producing an auditable record of the deliberation behind the finding.
“Does the available evidence support the criminal justice intervention's recidivism reduction claims at the proposed scale?”
Market entry decisions, M&A synergy assumptions, and supply chain resilience theses all carry evidence that needs adversarial pressure before capital is committed. Augle runs the pre-mortem your team won't — because it has no stake in the outcome.
“Does the M&A synergy thesis hold under independent examination of the integration assumptions and market overlap claims?”
Drug-drug interactions, health system partnerships, and digital therapeutics coverage decisions all depend on evidence with gaps that matter. Augle's Guardian operates in clinical integrity mode — flagging unverified sources, retracted studies, and the studies that simply don't exist yet.
“Is the drug-drug interaction evidence sufficient to contraindicate concurrent use in patients with moderate hepatic impairment?”
Infrastructure investment prioritisation, regulatory impact assessment, and public safety technology deployment decisions require evidence that can withstand public and legislative scrutiny. Augle produces the auditable deliberation record that accountability demands.
“Does the regulatory impact assessment adequately capture second-order economic effects in underserved communities?”
Model risk audits, ESG integration decisions, and sanctions compliance exposure reviews all require evidence that holds up to regulatory examination. Augle's Guardian operates in financial integrity mode — and the Synthesizer is architecturally forbidden from producing buy, sell, long, or short framing.
“Does the internal model's assumptions adequately capture tail risk under the Basel III stress scenarios?”
Algorithmic bias investigations, source credibility assessments, and science reporting standards all depend on the same thing: knowing what the evidence actually says versus what you've been told it says. Augle's SVS authenticates every source in real time — no hallucinated citations reach the finding.
“Is the algorithmic bias claim in the dataset robust to the methodological critiques raised in the academic literature?”
A wrong finding in a dissertation defence, a clinical review, or an investment thesis doesn't stay wrong — it propagates. Augle is built for questions where the cost of a confident wrong answer materially exceeds the cost of a calibrated uncertain one.
The questions that matter most don't have clean answers. They have conflicting studies, methodological disputes, and gaps where the relevant evidence doesn't exist yet. Augle maps that landscape precisely — settled, contested, unknown — instead of collapsing it into a single confident claim.
Every finding faces a Contrarian eventually — a committee member, an opposing partner, a regulator, a peer reviewer. Augle's Contrarian runs at temperature 1.0 and is required to steelman every claim before challenging it. Better to face the strongest version of the objection before the stakes are live.
Augle is built around question structure, not industry classification. If your question has contested evidence and real stakes, it's the right tool — regardless of which vertical it falls into. Browse the use case library to find sessions closest to yours.
Join waitlist and submit a session on a question that matters to your work.